Central support for Bharat Biotech, 3 PSEs to augment Covaxin supplies
The Hindu
The Centre has announced financial support to Covaxin maker Bharat Biotech as well as roped in Haffkine Bio-Pharmaceutical Corporation, Indian Immunologicals and Bharat Immunologicals and Biologicals,
The Centre has announced financial support to Covaxin maker Bharat Biotech as well as roped in Haffkine Bio-Pharmaceutical Corporation, Indian Immunologicals and Bharat Immunologicals and Biologicals, three firms in the public-sector fold, towards augmenting the production of the indigenously-developed COVID-19 vaccine. The current production capacity of Covaxin will be doubled by May-June and increased almost 6-7 fold by July-August 2021. In other words, the existing capacity of one crore doses a month will go up to 6-7 crore doses a month in July – August. It is expected to reach nearly 10 crore doses a month by September, a release from Union Ministry of Science and Technology said. As a part the augmentation plan, the production capacity of Bharat Biotech as well as the public sector vaccine makers are being upgraded with the required infrastructure and technology.More Related News